| |
| |
|
| Insider
Information: |
Belanoff Joseph K |
| Relationship: |
Chief Executive Officer |
| City: |
Menlo Park |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
348,811 |
|
|
Indirect Shares
|
2,483,107 |
|
|
| Direct
Value |
$10,105,055 |
|
|
|
Indirect Value
|
$71,935,610 |
|
|
| Total
Shares |
2,831,918 |
|
|
| Total
Value |
$82,040,664 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Corcept Therapeutics Inc |
CORT |
Chief Executive Officer |
2022-07-06 |
348,811 |
2022-07-07 |
2,483,107 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CORT |
Corcept Therapeutics Inc |
Chief Executive Officer |
• • – |
2021-01-22 |
4 |
OE |
$4.42 |
$3,536,000 |
D/D |
800,000 |
3,299,214 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Executive Officer |
• • – |
2019-03-20 |
4 |
OE |
$1.19 |
$931,633 |
D/D |
782,885 |
2,947,080 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Executive Officer |
• • – |
2021-01-22 |
4 |
D |
$28.06 |
$13,499,329 |
D/D |
(481,088) |
2,818,126 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
CHIEF EXECUTIVE OFFICER |
• • – |
2016-11-07 |
4 |
OE |
$1.50 |
$750,000 |
D/D |
500,000 |
2,570,662 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Executive Officer |
• – – |
2022-07-06 |
4 |
AS |
$26.27 |
$7,352,008 |
I/I |
(279,908) |
2,538,218 |
0 |
% |
|
| CORT |
Corcept Therapeutics Inc |
Chief Executive Officer |
• • – |
2019-03-20 |
4 |
D |
$11.93 |
$5,100,409 |
D/D |
(427,528) |
2,519,552 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Executive Officer |
• • – |
2020-02-26 |
4 |
D |
$13.54 |
$275,377 |
D/D |
(20,338) |
2,499,214 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Executive Officer |
• – – |
2022-07-07 |
4 |
AS |
$26.26 |
$1,446,945 |
I/I |
(55,111) |
2,483,107 |
0 |
% |
|
| CORT |
Corcept Therapeutics Inc |
CHIEF EXECUTIVE OFFICER |
• • – |
2016-11-10 |
4 |
OE |
$1.50 |
$450,000 |
D/D |
300,000 |
2,464,195 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Executive OfficerOfficer |
• • • |
2004-04-14 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,404,345 |
|
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Executive Officer |
• • • |
2004-11-01 |
4 |
AS |
$6.40 |
$16,000 |
D/D |
(2,500) |
2,401,845 |
|
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Executive Officer |
• • • |
2004-11-02 |
4 |
AS |
$6.00 |
$28,200 |
D/D |
(4,700) |
2,397,145 |
|
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Executive Officer |
• • • |
2004-11-03 |
4 |
AS |
$6.10 |
$3,660 |
D/D |
(600) |
2,396,545 |
|
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Executive Officer |
• • • |
2004-11-04 |
4 |
AS |
$6.01 |
$13,222 |
D/D |
(2,200) |
2,394,345 |
|
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Executive Officer |
• • • |
2004-12-07 |
4 |
AS |
$5.79 |
$57,934 |
D/D |
(10,000) |
2,384,345 |
|
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Executive Officer |
• • • |
2004-12-29 |
4 |
GD |
$0.00 |
$0 |
D/D |
150 |
2,384,195 |
|
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Executive Officer |
• • • |
2005-01-05 |
4 |
AS |
$6.00 |
$15,000 |
D/D |
(2,500) |
2,381,695 |
|
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Executive Officer |
• • – |
2018-12-12 |
4 |
OE |
$1.19 |
$258,367 |
D/D |
217,115 |
2,381,310 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Executive Officer |
• • • |
2005-01-19 |
4 |
AS |
$5.49 |
$17,014 |
D/D |
(3,100) |
2,378,595 |
|
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Executive Officer |
• • • |
2005-01-19 |
4 |
AS |
$5.16 |
$22,704 |
D/D |
(4,400) |
2,374,195 |
|
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Executive Officer |
• • • |
2005-02-15 |
4 |
AS |
$4.75 |
$23,750 |
D/D |
(5,000) |
2,369,195 |
|
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Executive Officer |
• • • |
2005-02-18 |
4 |
AS |
$4.49 |
$11,237 |
D/D |
(2,500) |
2,366,695 |
|
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Executive Officer |
• • • |
2005-02-22 |
4 |
AS |
$4.47 |
$11,175 |
D/D |
(2,500) |
2,364,195 |
|
- |
|
| CORT |
Corcept Therapeutics Inc |
CHIEF EXECUTIVE OFFICER |
• • – |
2016-11-11 |
4 |
OE |
$1.50 |
$300,000 |
D/D |
200,000 |
2,364,195 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Executive Officer |
• • • |
2005-03-04 |
4 |
AS |
$5.00 |
$6,250 |
D/D |
(1,250) |
2,362,945 |
|
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
